EUR 0.61
(-0.82%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 249.83 Million EUR | -6.42% |
2022 | 266.96 Million EUR | -54.83% |
2021 | 590.99 Million EUR | 2.41% |
2020 | 577.09 Million EUR | 9.35% |
2019 | 527.76 Million EUR | 5.37% |
2018 | 500.87 Million EUR | -2.39% |
2017 | 513.16 Million EUR | -24.19% |
2016 | 676.87 Million EUR | 0.2% |
2015 | 675.49 Million EUR | -12.85% |
2014 | 775.1 Million EUR | 4.76% |
2013 | 739.89 Million EUR | -1.46% |
2012 | 750.89 Million EUR | 4.56% |
2011 | 718.14 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 230.19 Million EUR | 0.0% |
2024 Q1 | 230.19 Million EUR | -7.86% |
2023 Q1 | 253.09 Million EUR | -5.2% |
2023 Q2 | 253.09 Million EUR | 0.0% |
2023 Q3 | 249.83 Million EUR | -1.29% |
2023 FY | 249.83 Million EUR | -6.42% |
2023 Q4 | 249.83 Million EUR | 0.0% |
2022 Q2 | 277.26 Million EUR | 0.0% |
2022 Q3 | 266.96 Million EUR | -3.71% |
2022 Q1 | 277.26 Million EUR | -53.09% |
2022 Q4 | 266.96 Million EUR | 0.0% |
2022 FY | 266.96 Million EUR | -54.83% |
2021 Q3 | 590.99 Million EUR | 0.4% |
2021 FY | 590.99 Million EUR | 2.41% |
2021 Q1 | 588.64 Million EUR | 2.0% |
2021 Q2 | 588.64 Million EUR | 0.0% |
2021 Q4 | 590.99 Million EUR | 0.0% |
2020 Q1 | 576.45 Million EUR | 9.22% |
2020 FY | 577.09 Million EUR | 9.35% |
2020 Q2 | 576.45 Million EUR | 0.0% |
2020 Q4 | 577.09 Million EUR | 0.0% |
2020 Q3 | 577.09 Million EUR | 0.11% |
2019 FY | 527.76 Million EUR | 5.37% |
2019 Q3 | 528.86 Million EUR | -2.6% |
2019 Q2 | 543 Million EUR | -1.42% |
2019 Q1 | 550.8 Million EUR | 9.97% |
2019 Q4 | 527.76 Million EUR | -0.21% |
2018 Q4 | 500.87 Million EUR | 1.46% |
2018 Q2 | 502.87 Million EUR | -1.38% |
2018 Q1 | 509.93 Million EUR | -0.63% |
2018 Q3 | 493.66 Million EUR | -1.83% |
2018 FY | 500.87 Million EUR | -2.39% |
2017 Q4 | 513.16 Million EUR | -0.48% |
2017 Q2 | 550.68 Million EUR | -18.23% |
2017 Q1 | 673.47 Million EUR | -0.5% |
2017 FY | 513.16 Million EUR | -24.19% |
2017 Q3 | 515.63 Million EUR | -6.36% |
2016 Q4 | 676.87 Million EUR | 24.11% |
2016 FY | 676.87 Million EUR | 0.2% |
2016 Q3 | 545.37 Million EUR | 0.0% |
2016 Q1 | - EUR | 0.0% |
2015 FY | 675.49 Million EUR | -12.85% |
2014 FY | 775.1 Million EUR | 4.76% |
2013 FY | 739.89 Million EUR | -1.46% |
2012 FY | 750.89 Million EUR | 4.56% |
2011 FY | 718.14 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Miliboo Société anonyme | 11.92 Million EUR | -1994.367% |
Neolife SA | 3.04 Million EUR | -8105.755% |
U10 Corp | 79.48 Million EUR | -214.339% |
Roche Bobois S.A. | 346.17 Million EUR | 27.829% |
SEB SA | 5.79 Billion EUR | 95.686% |
Vista Alegre Atlantis, SGPS, S.A. | 160.41 Million EUR | -55.741% |